Literature DB >> 7199042

Parenteral toxicological profile of the monocyclic beta-lactam antibiotic SQ 26,776 in mice, rats and dogs.

G R Keim, P L Sibley, F A Hines, M M Miller, A E Peterson, Y H Yoon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7199042     DOI: 10.1093/jac/8.suppl_e.141

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  Role of beta-lactamase in in vivo development of ceftazidime resistance in experimental Pseudomonas aeruginosa endocarditis.

Authors:  A S Bayer; J Peters; T R Parr; L Chan; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

2.  Evaluation of aztreonam in the treatment of severe bacterial infections.

Authors:  J Romero-Vivas; M Rodríguez-Créixems; E Bouza; T Hellín; A Guerrero; J Martínez-Beltrán; M García de la Torre
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

Review 3.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

4.  Single-dose pharmacokinetics of aztreonam in pediatric patients.

Authors:  H R Stutman; M I Marks; E A Swabb
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

5.  Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.

Authors:  E A Swabb; A A Sugerman; D N McKinstry
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

6.  Cephamycin inactivation due to enzymatic hydrolysis by beta-lactamase from Bacteroides fragilis.

Authors:  A Yotsuji; S Minami; H Kakizawa; T Yasuda; A Takai; I Saikawa; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

7.  Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.

Authors:  E A Swabb; A A Sugerman; T B Platt; F G Pilkiewicz; M Frantz
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.